Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China
Go back to Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China| (AMEX: ESAIY) | Delayed: 7.75 +0.05 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.70 | 52 Week High | $ | |||
| Open | $7.69 | 52 Week Low | $ | |||
| Day High | $7.77 | P/E | N/A | |||
| Day Low | $7.68 | EPS | $ | |||
| Volume | 62,859 | |||||
| Eisai Co Ltd (AMEX: ESALF) | Delayed: 29.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.90 | 52 Week High | $66.25 | |||
| Open | $29.90 | 52 Week Low | $53.50 | |||
| Day High | $29.90 | P/E | N/A | |||
| Day Low | $29.90 | EPS | $0.00 | |||
| Volume | 200 | |||||
